Study raises new possibilities of treating depression with magic mushroom compound


cientists are hopeful that a psychedelic compound unique to magic mushrooms could one day be used to treat people suffering from depression, after a new study showed it performed at least as effectively as a leading antidepressant currently prescribed to patients.

Researchers at Imperial College London found that psilocybin, a powerful hallucinogen that has similar effects to LSD, was capable of treating people with moderate-to-severe depression when combined with therapeutic support.

In a phase-two trial of 59 patients, the psychedelic was compared with an antidepressant called escitalopram, and worked more quickly in reducing self-reported depression scores.


Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more